Sero-Epidemiological Analysis of Hepatitis B Virus Infection among Apparently Healthy Young Adults in Omuaran-Community

Main Article Content

James A. Ndako
Stephen Ojo
Victor T. Dojumo
Victor O. Fajobi
Ilochi Ifeanyi
Jeremiah A. Akinwumi
Charity O. Akor


Hepatitis B (HBV) infection is an important public health concern all over the globe. As a result of its asymptomatic nature, its prevalence among apparently healthy individuals becomes relevant for studies. Hence the prevalence survey of hepatitis B virus was conducted among apparently healthy young individuals. A total of two hundred samples were screened from volunteer subjects for Hepatitis B surface Antigen (HBsAg), using the one step immune-chromatographic test strip manufactured by Dia Spot® Diagnostics. Questionnaires were administered to obtain relevant information and demographic data. Overall result showed that 11 (5.5%) of the subjects tested were found to be positive. The highest prevalence was found among subjects aged 22-26 years with 7.8% prevalence compared to those aged 12-21 years with 4.4% prevalence (P=0.1012); (p˃0.05). Based on demographic factors, female workers tend to demonstrate high positivity of 12.5% compared to male with 10.0% prevalence, (P=0.4929); (p˃0.05). Subjects involved with risky behavioral pattern by the use of unsterilized objects recorded a high prevalence of 5.3%, (P=0.5748); (p˃0.05) among female subjects. Serum Alanine amino-tranferases result showed no significant difference among the positive subjects. The results showed some measure of prevalence among the study population. It therefore becomes pertinent that the community be enlightened on the possible risk of infection by the virus. Efforts should be made to ensure vaccination against this infectious agent is intensified.

Epidemiological, hepatitis B virus, assay, infection, young-adults.

Article Details

How to Cite
Ndako, J. A., Ojo, S., Dojumo, V. T., Fajobi, V. O., Ifeanyi, I., Akinwumi, J. A., & Akor, C. O. (2020). Sero-Epidemiological Analysis of Hepatitis B Virus Infection among Apparently Healthy Young Adults in Omuaran-Community. International Journal of Pathogen Research, 4(4), 31-38.
Original Research Article


Maddrey WC. Hepatitis B: An important public health issue. Journal of Medical Virology. 2000;61:362-36.

Sharma R, Sharma CL, Khajuria R. The knowledge, attitude and practices regarding HBV infection of married women in the reproductive age group living in cantonment Area Sunjawan Jammu. Journal of Med. Educ. Res. 2004;6:127–130.

Okonko IO, Okerentugba PO, Adeniji FO, Anugweje KC. Detection of hepatitis B surface antigen (HBsAg) among intending apparently healthy blood donors. Nature and Science. 2012a;10(4).

World Health Organization (WHO). 2019-Fact Sheet Global Hepatitis Report; 2019.

Kire CF. The epidemiology and control of hepatitis B in Sub Saharan Africa. Prog Med Virology. 1993;40:143-56.

World Health Organization (WHO). 2009-Fact Sheet Global Hepatitis Report; 2009.

Esan AJ, Omisakin CT, Ojo-Bola T, Owoseni MF, Fasakin KA, Ogunleye AA. Sero-prevalence of hepatitis B and hepatitis C virus co-infection among pregnant women in Nigeria. American Journal of Biomedical Research. 2014;2(1):11-15.

Zuckerman AJ. More than third of world's population has been infected with hepatitis B virus. BMJ. 1999;318:1213.

Ezegbudo CN, Agba MI, Agbonlahor DE, Nwobu GO, Igwe CU, Agba MI. The seroprevalence of hepatitis B surface antigen and human immuno deficiency virus among pregnant women in Anambra state Nigeria. Shir E-Medical Journal. 2004;5:20–22.

Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis B surface antigen among blood donors and human immunodeficiency virus infected patients in Jos, Nigeria. Mom do Inst Oswaldo Cruz. 2005;100:13-16.

Kramvis A, Kew M. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37(Suppl 1):9–19.

Donbraye E, Japhet MO, Adesina AO, Abayomi OA. Prevalence of asymptomatic hepatitis B virus surface antigenemia in children in llesha, Osun State, South-Western Nigeria. Afr J Micro Res. 2014;8(23):2329–2331.

World Health Organization (WHO). 2001-Fact Sheet Global Hepatitis Report; 2002.

Shabir Lakhi, Yolan Banda, Kasonde Bowa, Sten H. Vermund, Joseph Mulenga, David Chama, Benjamin H. Chi. HIV, hepatitis B and hepatitis C in Zambia. 2011;3(3):269–274.

Ndako JA, Amina Y, Josphine OA, Olaolu DT, Akande TA. Hepatitis B virus infection among alcoholic consumers at a local community, North-East Nigeria. Journal of Natural Sciences Research. 2013;13(3): 23-29.

Umolu PI, Okoror LE, Orhue P. Human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenemia (HBsAg) among blood donors in Benin City, Edo state, Nigeria. African Journal of Health Sciences. 2005;5(1):55–58.

Ugwuja E, Ugwu N. Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria. The Internet Journal of Tropical Medicine. 2010;6(2).

Okonko IO, Okerentugba PO, Akinpelu AO. Prevalence of HBsAg among attendees of ARFH Centre in Ibadan, Southwestern Nigeria. American-Eurasian Journal of Scientific Research. 2012b;7(3): 100-105.

Olokoba AB, Salawu FK, Danburam A, Desalu OO, Olokoba LB, Wahab KW, Badung LH, Tidi SK, Midala J, Aderibigbe S, Abdulrahman MB, Babalola OM, Abdukkarim A. Viral hepatitides in voluntary blood donors in Yola, Nigeria. European Journal of Scientific Research. 2009;31(3):329-334.

Alli JA, Okonko IO, Abraham OA, Kolade AF, Ogunjobi PI, Tonade OO, Ojezele MO, Nwanze JC. A serosurvey of blood parasites (Plasmodium, Microfilaria, HIV, HBsAg, HCV antibodies) in prospective Nigerian blood donors. Research Journal in Medical Sciences. 2010;4(4):255-275.

Ejele OA, Ojule AC. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Nigerian Journal of Medicine. 2004;13:336-338.

Abdalla F, Mwanda OW, Rana F. Comparing walk-in and call-responsive donors in a national and a private hospital in Nairobi. East African Medical Journal. 2005;82(10):532-536.

Buseri FI, Muhibi MA, Jeremiah JA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, South-West Nigeria. Blood Transfusion. 2009;7(4):293-299.

Uneke CJ, Ogbu PU, Anyanwu GI, Njoku MO, Idoko JH. Prevalence of hepatitis B surface antigen among blood donors and HIV-infected patients in Jos, Nigeria. Memórias do Instituto Oswaldo Cruz Rio de Janerio. 2005;100(1):13-16.

Okonko IO, Udeze AO. Detection of hepatitis B surface antigen (HBsAg) among pregnant women attending Antenatal Clinic at O. L. A. Catholic Hospital, Oluyoro, Ibadan, Oyo State, Southwestern. Nature and Science. 2011;9(11):54-60.

Soriano V, Young B, Reau N. Report from the International Conference on Viral Hepatitis; AIDS Rev. 2017;19:1-13.

Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM et al., (Editors). Fields Virology, 4th Edition. Philadelphia: Lippincott William and Wilkins. 2001;2971-3036.

Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevalence of Hepatitis B infection in the Southeastern region of Turkey: Comparison of risk factors for HBV infection in rural and urban areas; 2005.

Balogun TM, Durojaiye IO, Sagoe A, Emmanuel S. Seroepidemiology of hepatitis-B surface antigenaemia in HIV positive patients. West Africa Journal of Medicine. 2010;29(3):169–173.

Olubuyide IO, Ola SO, Aliyu B, Dosumu OO, Arotiba JT. Hepatitis B and C in Doctors in Nigeria. Nigerian Quarterly Journal. Medicine. 1997;90:417-422.

Ola SO, Odaibo GN, Olaleye DO. HCV and HBV infections in Nigerian patients with liver cirrhosis and hepatocellular carcinoma. Nigerian Quarterly Journal of Medicine. 2004;14:3-4.

Lawal OA, Bakarey AS, Uche LN, Udeze AO, Okonko IO. HBV infection among intending blood donors who incidentally tested positive to HIV antibody in two blood banks in Ibadan, Nigeria. World Applied Science Journal. 2009;7(10):1269-1274.

Agbede OO, Iseniyi JO, Kolawole MO, Ojuawo A. Risk factors and seroprevalence of hepatitis B surface antigenaemia in mothers and their pre-school age children in Ilorin, Nigeria. Therapy. 2007;4(1):67-72.

Udeze AO, Aliyu AS, Kolawole OM, Okonko IO, Sule WF, Akanbi K. Hepatitis B surface antigenaemia and risk factors of transmission among apparently healthy students of University of Ilorin, Ilorin-Nigeria. Scientia Africana. 2012;2(11):1-8.

Ndako JA, Onwuliri FC, Banda JM, Alejolowo OO, Fajobi V, Olapade DO. Risk factors and prevalence of hepatitis B surface antigen (HBsAg) among apparently healthy volunteers in an urban setting, North-Central Nigeria. International Journal of Science. 2016;5(3):9-15.

DOI: 10.18483/ijSci.958

Goni BW, Yusuph H, Mustapha SK, Sahabi MA, Gwalabe SA, Tahir A, Bakki B, Kida IM. Hepatic transaminase and alkaline phosphatase enzyme levels in HIV/HBV co-infected and HIV mono-infected patients in Maiduguri, Nigeria. 2013;4(16):530-534.